Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
CHA University
CHA University
First Affiliated Hospital, Sun Yat-Sen University
Mayo Clinic
City of Hope Medical Center
Ohio State University
Aarhus University Hospital
Mayo Clinic
Mayo Clinic
Assistance Publique - Hôpitaux de Paris
National Institutes of Health Clinical Center (CC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Oslo University Hospital
Qilu Hospital of Shandong University
Johns Hopkins University
Zhejiang University
National Institutes of Health Clinical Center (CC)
Second Affiliated Hospital, School of Medicine, Zhejiang University
Tata Memorial Centre
Mayo Clinic
MarÃa Teresa Moreno Asencio
Shanghai Zhongshan Hospital
Shanghai Zhongshan Hospital
University Hospital, Bordeaux
M.D. Anderson Cancer Center
University of Nottingham
Cook Group Incorporated
Shanghai Jiao Tong University School of Medicine
Travera Inc
Erasmus Medical Center
CHA University
Erasmus Medical Center
Federation Francophone de Cancerologie Digestive
Peking Union Medical College Hospital
Alaunos Therapeutics
Alaunos Therapeutics
Seoul National University Hospital
Seoul National University Hospital
Germans Trias i Pujol Hospital
University of Washington
University Hospital, Bordeaux
Fujian Provincial Hospital
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
The First Affiliated Hospital of Air Force Medicial University
Region Skane
iOMEDICO AG
Clinique Paris-Bercy
Mayo Clinic
Fondazione IRCCS Policlinico San Matteo di Pavia
Kathmandu University School of Medical Sciences
Hadassah Medical Organization